Overview

Study of the Breast Milk Pharmacokinetics of Olanzapine and Samidorphan

Status:
Not yet recruiting
Trial end date:
2023-07-01
Target enrollment:
Participant gender:
Summary
This clinical lactation study is to provide information regarding the PK and amount of OLZ/SAM in breast milk and estimated infant exposure.
Phase:
Phase 1
Details
Lead Sponsor:
Alkermes, Inc.
Treatments:
Olanzapine